Q4 2024 Earnings Call Transcript March 13, 2025 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is ...
17h
MyChesCo on MSNEndo, Inc. Shares Positive Data on XIAFLEX Treatment for Peyronie’s DiseaseEndo, Inc. (OTCQX: NDOI) revealed new insights from a post hoc data analysis of its Phase 3 clinical trial of XIAFLEX® ...
It is one thing to ignore the easily found evidence of the effectiveness of vaccination, but it is incredibly worse and ...
Artificial intelligence can transform medicine in a myriad of ways, including its promise to act as a trusted diagnostic aide ...
The combination of DeSci and AI could transform scientific research, challenging traditional funding, publishing and ...
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results